Stratified Risk Score Developed for Burkitt's Lymphoma

Brown University researchers have developed a stratified risk score for patient prognosis in the treatment response of patients with Burkitt’s lymphoma.

The team of researchers was lead by Dr. Jorge Castillo, an assistant professor of medicine at the Warren Alpert Medical School of Brown University and a hematology/oncology specialist at Rhode Island Hospital.

The study

Castillo and colleagues looked at the records of 2,284 Burkitt's patients during a period of 11 years.

Using factors including survival rates, age, race, cancer location and cancer stage they created a risk score. Patients with the lowest score have a 7 of 10 chance of survival with treatment, while patients with a 10 have less than 3 in 10 chance of survival.

The findings

Investigators determined that age plays a huge role in survival; notably, patients older than 80 have a five times higher risk of dying from the disease than patients aged 20-39 years. Furthermore, advanced stage Burkitt's (Stage IV) patients are almost two and a half times at greater risk of of dying compared to those in early stages (Stage I).

Looking at the positive

Some good news included the fact that survival rates have been boosted substantially over time. For the younger patients, the rate of overall survival in 1998 was 34.7 percent compared to 62.1 percent today for this same patient population.

Oncologists can use this score to help them make treatment decisions as well as inform patients on their choices.

Burkitt's lymphoma is a rare subtype of non-Hodgkin's lymphoma. It is of B-cell origin and represents fewer than 2 percent of all lymphoid cancers.

Source: doctortipster

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...